CINECA IRIS Institutional Research Information System

BERTINI, SIMONE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.775
AS - Asia 4.721
EU - Europa 3.967
SA - Sud America 605
AF - Africa 158
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 2
Totale 19.238
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.506
SG - Singapore 1.594
IT - Italia 1.414
CN - Cina 1.257
HK - Hong Kong 700
DE - Germania 589
BR - Brasile 514
SE - Svezia 461
VN - Vietnam 371
BG - Bulgaria 324
TR - Turchia 265
FR - Francia 235
GB - Regno Unito 227
CA - Canada 207
FI - Finlandia 182
RU - Federazione Russa 157
IN - India 139
JP - Giappone 115
AT - Austria 99
UA - Ucraina 82
NG - Nigeria 62
KR - Corea 60
NL - Olanda 34
AR - Argentina 31
CH - Svizzera 27
MX - Messico 27
PK - Pakistan 26
BE - Belgio 25
IQ - Iraq 24
BD - Bangladesh 23
MA - Marocco 23
ID - Indonesia 21
SA - Arabia Saudita 19
CI - Costa d'Avorio 18
ES - Italia 17
PL - Polonia 16
GR - Grecia 15
ZA - Sudafrica 15
CZ - Repubblica Ceca 14
IL - Israele 14
UZ - Uzbekistan 13
EC - Ecuador 11
AU - Australia 9
CO - Colombia 9
VE - Venezuela 9
AZ - Azerbaigian 8
JO - Giordania 8
PH - Filippine 8
TN - Tunisia 8
UY - Uruguay 8
CL - Cile 7
EG - Egitto 7
PE - Perù 7
RO - Romania 7
RS - Serbia 7
IE - Irlanda 6
MY - Malesia 6
PA - Panama 6
PY - Paraguay 6
CR - Costa Rica 5
DO - Repubblica Dominicana 5
DZ - Algeria 5
KE - Kenya 5
KZ - Kazakistan 5
LB - Libano 5
NP - Nepal 5
TH - Thailandia 5
BA - Bosnia-Erzegovina 4
BY - Bielorussia 4
IR - Iran 4
JM - Giamaica 4
LT - Lituania 4
SN - Senegal 4
DM - Dominica 3
HN - Honduras 3
OM - Oman 3
PT - Portogallo 3
SK - Slovacchia (Repubblica Slovacca) 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
AM - Armenia 2
BB - Barbados 2
BJ - Benin 2
BO - Bolivia 2
CY - Cipro 2
DK - Danimarca 2
ET - Etiopia 2
EU - Europa 2
GE - Georgia 2
GH - Ghana 2
KG - Kirghizistan 2
LK - Sri Lanka 2
LU - Lussemburgo 2
PS - Palestinian Territory 2
QA - Qatar 2
SI - Slovenia 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
Totale 19.222
Salva come PNG Salva come JPEG
Città #
Ashburn 1.064
Woodbridge 1.037
Singapore 893
Ann Arbor 766
Hong Kong 691
Fairfield 656
Chandler 648
Houston 565
San Jose 506
Santa Clara 491
Serra 461
Dallas 376
Sofia 324
Shanghai 282
Cambridge 274
Beijing 259
Wilmington 256
Seattle 232
New York 202
Ottawa 170
Izmir 167
Boardman 147
Princeton 145
Lawrence 122
Lauterbourg 112
Milan 112
Los Angeles 107
Medford 107
Nanjing 98
Pisa 96
Tokyo 95
Jacksonville 88
Hefei 84
Vienna 84
Ho Chi Minh City 82
Munich 75
Dong Ket 74
Istanbul 70
Council Bluffs 68
Marseille 65
Redondo Beach 63
Lagos 62
Des Moines 60
London 60
Seoul 59
Hanoi 56
Nanchang 55
Buffalo 53
Dearborn 53
Florence 49
Helsinki 46
Redwood City 46
São Paulo 43
Columbus 40
Orem 37
Boulder 36
San Diego 36
The Dalles 34
Rome 30
Frankfurt am Main 28
Pune 26
Turku 26
Ogden 23
Brussels 22
Fuzhou 22
Nürnberg 22
Pistoia 22
Shenyang 22
Kunming 20
Guangzhou 19
San Francisco 19
Chennai 18
Norwalk 18
Nuremberg 18
Abidjan 17
Livorno 17
Mumbai 17
Bern 16
Chicago 16
Jakarta 15
Belo Horizonte 14
Hangzhou 14
Hyderabad 14
Warsaw 14
Jiaxing 13
Tianjin 13
Amsterdam 12
Atlanta 12
Baltimore 12
Casablanca 12
Jüchen 12
Lucca 12
Phoenix 12
Brooklyn 11
Hebei 11
Lappeenranta 11
Tashkent 11
Washington 11
Baghdad 10
Brasília 10
Totale 13.733
Salva come PNG Salva come JPEG
Nome #
Cytotoxic Activity of Oleocanthal Isolated from Virgin Olive Oil on Human Melanoma Cells 369
Oleocanthal and oleacein contribute to the in vitro therapeutic potential of extra virgin oil-derived extracts in non-melanoma skin cancer 254
Application of An Improved HPLC-FL Method to Screen Serine Palmitoyl Transferase Inhibitors 245
New quinolone- and 1,8-naphthyridine-3-carboxamides as selective CB2 receptor agonists with anticancer and immuno-modulatory activity 228
Polypharmacological profile of 1,2-dihydro-2-oxo-pyridine-3-carboxamides in the endocannabinoid system 222
Anti-proliferative activity of oleocanthal in human malignant cutaneous melanoma cells 221
Identification of the first synthetic allosteric modulator of the CB2receptors and evidence of its efficacy for neuropathic pain relief 220
Novel analogs of PSNCBAM-1 as allosteric modulators of cannabinoid CB1 receptor 216
Olive Mill Wastewater as Source of Polyphenols with Nutraceutical Properties 209
1,2-Dihydro-2-oxopyridine-3-carboxamides: the C-5 substituent is responsible for functionality switch at CB2 cannabinoid receptor 208
Synthesis of Anthranylaldoxime Derivatives as Estrogen Receptor Ligands and Computational Prediction of Binding Modes 206
Salicylaldoxime derivatives as new leads for the development of carbonic anhydrase inhibitors 203
Rational design, synthesis, biological evaluation and labelling of selective cannabinoid CB2 receptor agonists as anticancer agents 201
Composition of health-promoting phenolic compounds in two extra-virgin olive oils and diversity of associated yeasts 201
Synthesis and pharmacological evaluation of new biphenylic derivatives as CB2 receptor ligands 201
Salicylaldoximes and anthranylaldoximes as alternatives to phenol-based estrogen receptor ligands 200
Synthesis of stable analogues of geranylgeranyl diphosphate possessing a (Z,E,E)-geranylgeranyl side chain, docking analysis, and biological assays for prenyl protein transferase inhibition 200
Synthesis, biological activity and molecular modeling of new biphenylic carboxamides as potent and selective CB2 receptor ligands 200
Salicylaldoximes and anthranylaldoximes as alternatives to phenol-based estrogen receptor ligands 199
Development of an HPLC/UV assay for the evaluation of inhibitors of human recombinant monoacylglycerol lipase 199
Inhibitors of lactate dehydrogenase isoforms and their therapeutic potentials 199
Allosteric modulators targeting cannabinoid cb1 and cb2 receptors: Implications for drug discovery 199
Efficient application of monolithic silica column to determination of illicit heroin street sample by HPLC 197
Antiproliferative oxime derivatives that inhibit glucose transporter 1 (GLUT1) in cancer cells 195
Design, synthesis and preliminary evaluation of (18)F-labelled 1,8-naphthyridin- and quinolin-2-one-3-carboxamide derivatives for PET imaging of CB2 cannabinoid receptor 194
Phosphonomethylphosphorylmethyl(oxy)-analogues of geranylgeranyl diphosphate as stable and selective geranylgeranyl protein transferase inhibitors 192
Sulfonamido-derivatives of unsubstituted carbazoles as BACE1 inhibitors 191
4-[6-(dansylamino)hexylamino]-7-methyl-2-phenyl-1,8-naphthyridine as a new potential fluorescent probe for studying A1-adenosine receptor 191
Modification on the 1,2-dihydro-2-oxo-pyridine-3-carboxamide core to obtain multi-target modulators of endocannabinoid system 191
CB2-Selective Cannabinoid Receptor Ligands: Synthesis, Pharmacological Evaluation, and Molecular Modeling Investigation of 1,8-Naphthyridin-2(1H)-one-3-carboxamides 190
Estrogen receptor ligands: a patent review update 187
Highly Selective Salicylketoxime-Based Estrogen Receptor β Agonists Display Antiproliferative Activities in a Glioma Model 185
Selective and potent agonists for estrogen receptor beta derived from molecular refinements of salicylaldoximes 182
7-Nitrobenzofurazan (NBD)-Derivatives Of 5'-N-Ethylcarboxamidoadenosine (NECA) As New Fluorescent Probes For Human A3 Adenosine Receptors 179
Diaryl-substituted salicyl- and anthranyl-ketoximes as potential estrogen receptor ligands 178
Immunomodulatory properties of 1,2-dihydro-4-hydroxy-2-oxo-1,8-naphthyridine-3-carboxamide derivative VL15 177
Variously substituted (phosphonoacetamido)oxy analogues of geranylgeranyl diphosphate (GGdP) as GGdP-transferase (GGTase) inhibitors and antiproliferative agents 177
Selective activators of estrogen receptor beta based on the aldoxime and ketoxime scaffolds 175
Oxime-based inhibitors of glucose transporter 1 displaying antiproliferative effects in cancer cells 174
Synthesis of aniline-type analogues of farnesyl diphosphate and their biological assays for prenyl protein transferase inhibitory activity 169
Synthesis of a Resveratrol Analogue with High Ceramide-Mediated Proapoptotic Activity on Human Breast Cancer Cells 168
Biphenyl-Derivatives Possessing Tertiary Amino Groups as ß-Secretase (BACE1) Inhibitors 166
BACE1 inhibitory activities of enantiomerically pure, variously substituted N-(3-(4-benzhydrylpiperazin-1-yl)-2-hydroxypropyl) arylsulfonamides 163
Rational design, synthesis and anti-proliferative properties of new CB2 selective cannabinoid receptor ligands: An investigation of the 1,8-naphthyridin-2(1H)-one scaffold 161
Machine Learning-Based Virtual Screening for the Identification of Cdk5 Inhibitors 160
Ceramide analogues in apoptosis: a new strategy for anticancer drug development 160
Metabolically labile cannabinoid esters: A ‘soft drug’ approach for the development of cannabinoid-based therapeutic drugs 159
200 Esercizi Risolti di Chimica Generale ed Inorganica 156
Novel Estrogen Receptor Ligands Based on an Anthranylaldoxime Structure: Role of the Phenol-Type Pseudocycle in the Binding Process 154
Synthesis and antiviral properties of novel analogues of monophosphate and diphosphate bioactive forms of acyclovir 153
CB1 receptor binding sites for NAM and PAM: A first approach for studying, new n‑butyl‑diphenylcarboxamides as allosteric modulators 153
Aminobenzothiazoles as beta-Selective Estrogen Receptor Ligands 152
Antiproliferative activity and cell cycle analysis of 2-(3,5-dihydroxyphenyl)-6-hydroxybenzothiazole on MCF-7 breast and HCT-15 colon cancer cell lines. 151
Carbazole-containing arylcarboxamides as BACE1 inhibitors 151
Development of Methods for Recovering Endotoxins from Surfaces and from Air in Production Environment of Injectable Drugs 151
Synthesis, Antifungal Activity, and Molecular Modeling Studies of New Inverted Oxime Ethers of Oxiconazole 149
Conformationally restrained ceramide analogues: effects of lipophilic modifications on the antiproliferative activity 149
Study of apoptosis induction and deoxycytidine kinase/cytidine deaminase modulation in the synergistic interaction of a novel ceramide analog and gemcitabine in pancreatic cancer cells 149
Multi-targeted ChEI-copper chelating molecules as neuroprotective agents 149
Design, synthesis, and characterization of the antitumor activity of novel ceramide analogues 148
18FLUORINE-LABELED NITROGEN HETEROCYCLIC DERIVATIVES AS NEW CANDIDATE FOR CANNABINOID CB2 RECEPTOR PET IMAGING 147
Medicinal Chemistry approach, pharmacology and neuroprotective benefits of CB2R modulators in neurodegenerative diseases 145
Synthesis of heterocycle-based analogs of resveratrol and their antitumor and vasorelaxing properties 144
SERINE PALMITOYLTRANSFERASE INHIBITION: A VIRTUAL SCREENING HYPOTHESIS 142
A theoretical study to investigate D2DAR/D4DAR selectivity: Receptor modeling and molecular docking of dopaminergic ligands 142
Aromatic aldoximes as Estrogen Receptor Beta–Selective Ligands 142
Aminobenzothiazoles as inhibitors of tau-fibril formation in Alzheimer's and other neurodegenerative diseases 139
N6-isopentenyladenosine arrests tumor cell proliferation by inhibiting farnesyl diphosphate synthase and protein prenylation 139
The endocannabinoid system dual-target ligand N-cycloheptyl-1,2-dihydro-5-bromo-1-(4-fluorobenzyl)-6-methyl-2-oxo-pyridine-3-carboxamide improves disease severity in a mouse model of multiple sclerosis 139
Novel Potent and Selective Agonists of the GPR55 Receptor Based on the 3-Benzylquinolin-2(1H)-One Scaffold 138
alpha-Naphthylaminopropan-2-ol Derivatives as BACE1 Inhibitors 138
Traditional Uses of Cannabinoids and New Perspectives in the Treatment of Multiple Sclerosis 138
Monoaryl-substituted Salicylaldoximes as Ligands for Estrogen Receptor Beta 136
Radiosensitizing potential of small organic molecules toward hypoxic tumor cells in the radiotherapy 134
Attività antiproliferativa dell’oleocantale in cellule umane di melanoma cutaneo maligno. 133
Stable propylphosphonic acid analogues of geranylgeranyl diphosphate possessing inhibitory activity on geranylgeranyl protein transferase 132
Salicylaldoxime moiety as a phenolic “A-ring” substitute in estrogen receptor ligands 132
Content Variations in Oleocanthalic Acid and Other Phenolic Compounds in Extra-Virgin Olive Oil during Storage 132
Stable analogues of geranylgeranyl diphosphate possessing a (Z,E,E)-geranylgeranyl side-chain as inhibitors of prenyl protein transferases 131
Stable analogues of geranylgeranyl diphosphate endowed of improved geranylgeranyl vs. farnesyl protein transferase inhibitory selectivity 130
1-Acetoxypinoresinol, a Lignan from Olives: Insight into Its Characterization, Identification, and Nutraceutical Properties 129
Purification, Enzymatic Characterization and Inhibition of the Z-Farnesyl Diphosphate Synthase from Mycobacterium tuberculosis 128
Enhanced Nutraceutical Properties of Extra Virgin Olive Oil Extract by Olive Leaf Enrichment 126
PSNCBAM-1 analogs: Structural evolutions and allosteric properties at cannabinoid CB1 receptor 126
Insights into the Antioxidant/Antiradical Effects and In Vitro Intestinal Permeation of Oleocanthal and Its Metabolites Tyrosol and Oleocanthalic Acid 125
Synthesis of 18F-labeled nitrogen heterocyclic derivatives as new candidate for cannabinoid CB2 receptor PET imaging 125
Salicylaldoxime Moiety as a Phenolic "A-Ring" Substitute in Estrogen Receptor Ligands 124
Assessment of a HPLC assay for monoacylglycerol lipase activity 124
Comparative Analysis on Polyphenolic Composition of Different Olive Mill Wastewater and Related Extra Virgin Olive Oil Extracts and Evaluation of Nutraceutical Properties by Cell-Based Studies 123
Cannabinoid-Based Medicines and Multiple Sclerosis 123
Predictions of binding of estrogen receptor agonists by a combination of molecular dynamics and continuum solvent models 122
Synthetic hydroxylated aryl-naphthalene derivatives as resveratrol rigid analogues showing ceramide-mediated antiproliferative and pro-apoptotic properties 121
Alzheimer Diseases: Design and synthesis of new BACE inhibitors 120
Synthesis, binding affinity, and transcriptional activity of hydroxy- and methoxy-Substituted 3,4-Diarylsalicylaldoximes on estrogen receptors a and ß 119
Structural Evolutions of Salicylaldoximes as Selective Agonists for Estrogen Receptor Beta 119
Synthesis and Biology of NBD-Derivatives of Neca as New Fluorescent Probes for Adenosine Receptors 119
N-Metilantranilaldossime aril-sostituite come ligandi estrogenici 117
Synthesis and biological evaluation of new compounds as cannabinoid receptor type 1 allosteric modulators 116
New biphenylic derivatives as CB2 receptor selective ligands 112
Salicylaldoxime-Based Ligands for Estrogen Receptor Beta Showing Potent Agonist Properties 111
Totale 16.408
Salva come PNG Salva come JPEG
Categoria #
all - tutte 52.727
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 52.727
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021227 0 0 0 0 0 0 0 0 0 0 59 168
2021/20221.478 30 184 53 52 225 185 61 76 31 51 77 453
2022/20231.831 210 276 145 158 246 241 11 134 267 12 85 46
2023/20241.042 105 104 106 43 147 203 83 37 17 19 41 137
2024/20253.927 20 164 87 256 401 404 299 197 436 515 421 727
2025/20264.339 307 530 471 340 459 454 725 246 298 405 104 0
Totale 19.583